Cargando…
What is the risk of prostate cancer mortality following negative systematic TRUS-guided biopsies? A systematic review
OBJECTIVE: To investigate the risk of prostate cancer-specific mortality (PCSM) following initial negative systematic transrectal ultrasound-guided (TRUS) prostate biopsies. DESIGN: Systematic review. DATA SOURCES: PubMed and Embase were searched using a string combination with keywords/Medical Subj...
Autores principales: | Kawa, Sandra Miriam, Benzon Larsen, Signe, Helgstrand, John Thomas, Iversen, Peter, Brasso, Klaus, Røder, Martin Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7751212/ https://www.ncbi.nlm.nih.gov/pubmed/33371032 http://dx.doi.org/10.1136/bmjopen-2020-040965 |
Ejemplares similares
-
Diagnosis and Monitoring of Prostatic Lesions: A Comparison of Three Modalities: Multiparametric MRI, Fusion MRI/Transrectal Ultrasound (TRUS), and Traditional TRUS
por: Birs, Antoinette, et al.
Publicado: (2016) -
MR-targeted TRUS prostate biopsy using local reference augmentation: initial experience
por: van de Ven, Wendy J. M., et al.
Publicado: (2016) -
Short-term morbidity and mortality following radical cystectomy: a systematic review
por: Maibom, Sophia Liff, et al.
Publicado: (2021) -
Danish Prostate Registry (DanProst) – an Updated Version of the Danish Prostate Cancer Registry, Methodology, and Early Results
por: Stroomberg, Hein Vincent, et al.
Publicado: (2023) -
Comparison of pain levels in fusion prostate biopsy and standard TRUS-Guided biopsy
por: Demirtaş, Abdullah, et al.
Publicado: (2020)